Clinical Trials Insight: 700029254
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2012
At a glance
- Drugs Brincidofovir (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Chimerix
- 05 Mar 2012 Results published in Antimicrobial Agents and Chemotherapy.
- 06 Jan 2009 Status changed from recruiting to completed according to a Chimerix media release.
- 13 Dec 2007 New trial record.